- Home
- ACIU vs CPS Comparison
ACIU vs CPS Comparison
Compare ACIU & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | CPS |
|---|---|---|
| Founded | 2003 | 1960 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 562.6M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | CPS |
|---|---|---|
| Price | $3.14 | $33.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $10.00 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 1.3M | 147.3K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.84 |
| Revenue | $5,482,957.00 | ★ $2,729,297,000.00 |
| Revenue This Year | N/A | $0.22 |
| Revenue Next Year | $738.95 | $6.65 |
| P/E Ratio | ★ N/A | $17.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $10.38 |
| 52 Week High | $4.00 | $40.67 |
Technical Indicators
Market Signals| Indicator | ACIU | CPS |
|---|---|---|
| Relative Strength Index (RSI) | 55.61 | 59.97 |
| Support Level | $2.54 | $29.67 |
| Resistance Level | $2.99 | $30.70 |
| Average True Range (ATR) | 0.29 | 1.08 |
| MACD | 0.03 | 0.40 |
| Stochastic Oscillator | 50.40 | 86.81 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.